Studies involving disease:Fatty liver disease
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST000194 | Lanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitis | Mouse | University of Michigan |
| ST000254 | The role of microbial metabolites in experimental liver disease | Mouse | University of North Carolina |
| ST000665 | Nonalcoholic fatty liver disease (NAFLD) Studies | Human | University of Michigan |
| ST000677 | Nonalcoholic steatohepatitis (NASH) changes with S.Q. Leptin administrations | Human | University of Michigan |
| ST000678 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) | Human | University of Michigan |
| ST000679 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part II | Human | University of Michigan |
| ST000680 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part III | Human | University of Michigan |
| ST000693 | Lanthanide-mineral induced alteration of bile acid metabolism in a murine model of steatohepatitis (part II) | Mouse | University of Michigan |
| ST000779 | Lipidomics pilot project for mice exposure to bisphenol A and high fat diets | Mouse | University of Michigan |
| ST000915 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 1:Liver | Human | LIPID MAPS |
| ST000916 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | Human | LIPID MAPS |
| ST000917 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine | Human | LIPID MAPS |
| ST000977 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) | Human | University of California, Davis |
| ST000993 | Tibetan medicine Shi-Wei-Gan-Ning-Pill (SWGNP) protect rats from ccl4 induced liver fibrosis.(Part I: Liver) | Rat | Nanjing University of Science & Technology |
| ST000994 | Tibetan medicine Shi-Wei-Gan-Ning-Pill (SWGNP) protect rats from ccl4 induced liver fibrosis (Part II: Serum) | Rat | Nanjing University of Science & Technology |
| ST001185 | Genetic and metabolic characterization of bioengineered human fatty liver tissue with modified SIRT1 expression | Human | University of Pittsburgh |
| ST001428 | Role of environmental toxicants in modulating disease severity in children with NAFLD | Human | Emory University |
| ST001680 | Metabolome of NAFLD in high fat diet mouse model | Mouse | Weill Cornell Medicine |
| ST001710 | Metabolic signatures of NAFLD - Lipidomics data (part 1 of 3) | Human | Örebro University |
| ST001711 | Metabolic signatures of NAFLD - Polar metabolomics data (part II) | Human | Örebro University |
| ST001842 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part I) | Human | University of California, Davis |
| ST001843 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Human | University of California, Davis |
| ST001844 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) | Human | University of California, Davis |
| ST001845 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part V) | Human | University of California, Davis |
| ST001919 | Exposure to environmental contaminants is associated with alterations in hepatic lipid metabolism in non-alcoholic fatty liver disease | Mouse | Örebro University |
| ST001964 | Quantitative genome-scale analysis of human liver reveals dysregulation of glycosphingolipid pathways in progressive nonalcoholic fatty liver disease | Human | University of Turku |
| ST002091 | Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico | Human | University of California, Los Angeles |
| ST002156 | Mouse liver metabolites | Mouse | University of Missouri-Columbia |
| ST002182 | Amelioration of developmental programming of NAFLD in weanling liver using PQQ | Mouse | University of Oklahoma Health Sciences Center |
| ST002191 | Amelioration of developmental programming of NAFLD in fetal liver using PQQ | Mouse | University of Oklahoma Health Sciences Center |
| ST002192 | Amelioration of developmental programming of NAFLD in adult liver using PQQ | Mouse | University of Oklahoma Health Sciences Center |
| ST002269 | Targeted plasma metabolomics in pediatric NAFLD patients | Human | Seoul National University College of Medicine and Hospital |
| ST002514 | The investigation of the role of dietary inulin in NASH progression with mouse fecal metabolites | Mouse | The Chinese University of Hong Kong |
| ST002520 | The investigation of the role of dietary inulin in Non-alcoholic Steatohepatitis (NASH) progression with portal vein serum metabolites | Mouse | The Chinese University of Hong Kong |
| ST002754 | Metabolomics analysis of maternal obesity model | Mouse | University of Bonn |
| ST002781 | Lipidomics analysis of maternal obesity model - wild type | Mouse | University of Bonn |
| ST002782 | Lipidomics analysis of maternal obesity model - knock out | Mouse | University of Bonn |
